Patient Opportunity Trust Class IS
MVISX
NASDAQ
| Weiss Ratings | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Company Info | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Patient Capital Management | |||
| Manager/Tenure (Years) | Samantha McLemore (17), Christina Malbon (2) | |||
| Website | http://www.patientcapitalmanagement.com | |||
| Fund Information | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Patient Opportunity Trust Class IS | |||
| Category | Mid-Cap Value | |||
| Sub-Category | US Equity Mid Cap | |||
| Prospectus Objective | Growth | |||
| Inception Date | Aug 22, 2018 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 1,000,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.19% | |||
| Dividend | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.42% | |||
| Asset Allocation | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.07% | |||
| Stock | 97.35% | |||
| U.S. Stock | 89.88% | |||
| Non-U.S. Stock | 7.47% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 2.57% | |||
| Price History | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.08% | |||
| 30-Day Total Return | -2.45% | |||
| 60-Day Total Return | -7.56% | |||
| 90-Day Total Return | -6.57% | |||
| Year to Date Total Return | -5.26% | |||
| 1-Year Total Return | 43.33% | |||
| 2-Year Total Return | 39.58% | |||
| 3-Year Total Return | 95.09% | |||
| 5-Year Total Return | 12.64% | |||
| Price | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $51.33 | |||
| 1-Month Low NAV | $48.57 | |||
| 1-Month High NAV | $53.54 | |||
| 52-Week Low NAV | $32.69 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $57.66 | |||
| 52-Week High Price (Date) | Jan 09, 2026 | |||
| Beta / Standard Deviation | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.60 | |||
| Standard Deviation | 21.88 | |||
| Balance Sheet | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.84B | |||
| Operating Ratios | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.42% | |||
| Turnover Ratio | 27.00% | |||
| Performance | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 24.64% | |||
| Last Bear Market Total Return | -29.42% | |||